Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
The Journal of Pathology
|
April 30, 2009
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma
Raffaella De Maria, Silvia Miretti, Selina Iussich, et al.
Cell Death & Disease
|
February 9, 2023
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
Marta Falcinelli, Giulia Dell'Omo, Elena Grassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2023
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer
Simonetta M Leto, Martina Ferri, Francesco Sassi, et al.
Journal of the National Cancer Institute
|
October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Nature Genetics
|
July 11, 2022
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells
Mariangela Russo, Simone Pompei, Alberto Sogari, et al.
Bioinformatics (Oxford, England)
|
April 20, 2023
CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system
Simone Pernice, Roberta Sirovich, Elena Grassi, et al.
International Journal of Cancer
|
July 24, 2020
Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer
Andreas U Lindner, Steven Carberry, Naser Monsefi, et al.
Cancer Research
|
February 15, 2014
NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells
Anna Pastò, Valentina Serafin, Giorgia Pilotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy
Paolo Luraghi, Viola Bigatto, Elia Cipriano, et al.
Cancer Discovery
|
August 6, 2015
HER2 activating mutations are targets for colorectal cancer treatment
Shyam M Kavuri, Naveen Jain, Francesco Galimi, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
The Journal of Pathology
|
April 30, 2009
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma
Raffaella De Maria, Silvia Miretti, Selina Iussich, et al.
Cell Death & Disease
|
February 9, 2023
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
Marta Falcinelli, Giulia Dell'Omo, Elena Grassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2023
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer
Simonetta M Leto, Martina Ferri, Francesco Sassi, et al.
Journal of the National Cancer Institute
|
October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Nature Genetics
|
July 11, 2022
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells
Mariangela Russo, Simone Pompei, Alberto Sogari, et al.
Bioinformatics (Oxford, England)
|
April 20, 2023
CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system
Simone Pernice, Roberta Sirovich, Elena Grassi, et al.
International Journal of Cancer
|
July 24, 2020
Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer
Andreas U Lindner, Steven Carberry, Naser Monsefi, et al.
Cancer Research
|
February 15, 2014
NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells
Anna Pastò, Valentina Serafin, Giorgia Pilotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy
Paolo Luraghi, Viola Bigatto, Elia Cipriano, et al.
Cancer Discovery
|
August 6, 2015
HER2 activating mutations are targets for colorectal cancer treatment
Shyam M Kavuri, Naveen Jain, Francesco Galimi, et al.
Page
of 10